Variant report
Variant | nsv556278 |
---|---|
Chromosome Location | chr11:106958304-107006900 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:106989221..106991888-chr11:106999463..107001388,2 | K562 | blood: | |
2 | chr11:106999107..107000959-chr11:107001303..107003964,3 | K562 | blood: | |
3 | chr11:106999107..107000959-chr11:107001303..107003964,3 | K562 | blood: | |
4 | chr11:106989221..106991888-chr11:106999463..107001388,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs376215109 | chr11:106962406-106962407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75121761 | chr11:106962471-106962472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373707398 | chr11:106962482-106962483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182105862 | chr11:106962484-106962485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554022818 | chr11:106962496-106962497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541801706 | chr11:106962514-106962515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73000321 | chr11:106962523-106962524 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs186660610 | chr11:106962528-106962529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554592919 | chr11:106962544-106962545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs74716022 | chr11:106962559-106962560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576438223 | chr11:106962585-106962586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377446042 | chr11:106973438-106973439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573285118 | chr11:106973439-106973440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567818434 | chr11:106973520-106973521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs56259394 | chr11:106973604-106973605 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs549730844 | chr11:106973622-106973623 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571330956 | chr11:106973656-106973657 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538676035 | chr11:106973668-106973669 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553960124 | chr11:106973674-106973675 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572547733 | chr11:106973683-106973684 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533701343 | chr11:106973687-106973688 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11212032 | chr11:106973692-106973693 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183750222 | chr11:106973706-106973707 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544538223 | chr11:106973728-106973729 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79238197 | chr11:106973730-106973731 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1840568 | chr11:106973788-106973789 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs186887325 | chr11:106973789-106973790 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559990756 | chr11:106973794-106973795 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs191784950 | chr11:106973819-106973820 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549271988 | chr11:106973820-106973821 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561163569 | chr11:106973862-106973863 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs139026530 | chr11:106973875-106973876 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34657554 | chr11:106973879-106973880 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184995221 | chr11:106973883-106973884 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571642837 | chr11:106973899-106973900 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538644070 | chr11:106973900-106973901 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373055210 | chr11:106973934-106973935 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574011987 | chr11:106973950-106973951 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565999180 | chr11:106973951-106973952 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs2462397 | chr11:106973966-106973967 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs11824598 | chr11:106973982-106973983 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555241712 | chr11:106973985-106973986 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2465776 | chr11:106974038-106974039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538069667 | chr11:106974069-106974070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556485582 | chr11:106974172-106974173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs578034523 | chr11:106974183-106974184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1598456 | chr11:106974257-106974258 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs190278675 | chr11:106974277-106974278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181880613 | chr11:106974291-106974292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372699759 | chr11:106974356-106974357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Obesity | 19966786 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 21811512 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:106962400-106962600 | Weak transcription | Pancreas | Pancrea |
2 | chr11:106973400-106973600 | Enhancers | HepG2 | liver |
3 | chr11:106973400-106973800 | Enhancers | Spleen | Spleen |
4 | chr11:106973400-106974200 | Enhancers | Fetal Muscle Leg | muscle |
5 | chr11:106973600-106974000 | Enhancers | Fetal Brain Female | brain |
6 | chr11:106973600-106974000 | Flanking Active TSS | HepG2 | liver |
7 | chr11:106973600-106974600 | Enhancers | Fetal Heart | heart |
8 | chr11:106973600-106975000 | Enhancers | Fetal Muscle Trunk | muscle |
9 | chr11:106974000-106974200 | Enhancers | HepG2 | liver |
10 | chr11:106986800-106987600 | Enhancers | Placenta Amnion | Placenta Amnion |
11 | chr11:106987200-106987600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr11:106987400-106988800 | Enhancers | Fetal Intestine Small | intestine |
13 | chr11:106987800-106988200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
14 | chr11:106988200-106991400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr11:106988800-106992600 | Weak transcription | Fetal Intestine Small | intestine |
16 | chr11:106991400-106991800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr11:106991400-106992200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
18 | chr11:106992200-106993800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr11:107001800-107003600 | Enhancers | Fetal Intestine Large | intestine |
20 | chr11:107002200-107003200 | Enhancers | Fetal Intestine Small | intestine |